Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports

BACKGROUND: Congenital myasthenic syndromes (CMSs) are a heterogeneous group of neuromuscular disorders. Mutations of the nicotinic acetylcholine receptor epsilon subunit gene (CHRNE) are the most common causes of these disorders. CMSs are gaining increasing recognition by clinicians. However, pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kun, Luo, Yue-Bei, Bi, Fang-Fang, Yang, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573743/
https://www.ncbi.nlm.nih.gov/pubmed/32727330
http://dx.doi.org/10.2174/1570159X18666200729092332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573743/
https://www.ncbi.nlm.nih.gov/pubmed/32727330
http://dx.doi.org/10.2174/1570159X18666200729092332

Ejemplares similares